Note: Ingredients listed on restricted chemical lists
EC/CAS
233-139-2/10043-35-3
Name of the chemical
Borsäure Borsäure
Concentration
0.1 - 0.25
General Information
Version
1.0
Revision date
2023-10-26
Product name
Plantafol 5-15-45
1.2.1 Relevant identified uses
Industrial/Professional use spec
Emergency telephone
(+39) 08728811
Icons in SDS
Company Information
company name
VALAGRO Spa
e-mail address of the competent person responsible for the Safety Data Sheet
regulatory@valagro.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P280 - Wear eye protection, face protection, protective gloves. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents/container to comply with applicable local, national and regulation.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component boric acid (10043-35-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component boric acid(10043-35-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
